What is the treatment for tinea pedis (athlete's foot)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Pedis

First-Line Treatment: Topical Terbinafine

For interdigital tinea pedis, apply topical terbinafine 1% cream twice daily for 1 week, which is the most effective first-line treatment and superior to longer courses of other antifungal agents. 1, 2

Topical Terbinafine Dosing by Location

  • Between the toes (interdigital): Apply twice daily for 1 week 1, 2
  • Bottom or sides of the foot (moccasin-type): Apply twice daily for 2 weeks 2
  • Terbinafine's fungicidal action allows for these shorter treatment durations compared to fungistatic agents like azoles 3

Alternative Topical Agents

  • Ciclopirox olamine 0.77% cream/gel: Achieves approximately 60% clinical and mycological cure at end of treatment, increasing to 85% two weeks after treatment 1
  • Clotrimazole 1% cream: Less effective than terbinafine but widely available over-the-counter; requires twice daily application for 4 weeks 1, 3
  • Other options include ketoconazole, tolnaftate, and amorolfine for 1-6 weeks 4

Oral Therapy for Severe or Resistant Cases

Reserve oral antifungal therapy for severe disease, failed topical therapy, concomitant onychomycosis, or immunocompromised patients. 1, 4

Oral Treatment Options (in order of preference)

  • Terbinafine 250 mg once daily for 1-2 weeks: First-line systemic treatment with over 70% oral absorption unaffected by food, fungicidal action, and higher efficacy against dermatophytes than itraconazole 1
  • Itraconazole: Alternative dosing includes 100 mg daily for 2 weeks, or pulse dosing at 200-400 mg per day for 1 week per month, though it has slightly lower efficacy and potentially higher relapse rates than terbinafine 1
  • Fluconazole 150 mg once weekly: Less effective than both terbinafine and itraconazole but useful when other agents are contraindicated due to fewer drug interactions 1
  • Griseofulvin: Not recommended as first-line due to lower efficacy and longer treatment duration 1

Special Population Considerations

  • Diabetic patients: Prefer terbinafine over itraconazole due to lower risk of drug interactions and hypoglycemia 1
  • Athletes: Require minimum 72 hours of antifungal therapy before return to contact sports, with lesions covered appropriately 1

Prevention Strategies to Reduce Recurrence

Implement comprehensive prevention measures as tinea pedis has high recurrence rates due to environmental contamination and reinfection. 5, 1

Patient Education and Hygiene

  • Apply foot powder after bathing, which can reduce tinea pedis rates from 8.5% to 2.1% 1
  • Thoroughly dry between toes after showering 1
  • Change socks daily and wear cotton, absorbent socks 5
  • Clean athletic footwear periodically 1
  • Always wear protective footwear in public bathing facilities, gyms, and hotel rooms 5

Footwear Management

  • Discard old, moldy footwear when possible 5
  • If discarding is not feasible, place naphthalene mothballs in shoes and seal in plastic bag for minimum 3 days to eliminate fungal elements 5
  • Apply antifungal powders containing miconazole, clotrimazole, or tolnaftate inside shoes 5
  • Alternatively, spray terbinafine solution into shoes periodically 5

Preventing Spread

  • Cover active foot lesions with socks before wearing underwear to prevent spread to groin area 1
  • Treat all infected family members simultaneously to prevent reinfection 5, 1
  • Avoid sharing toenail clippers with family members 5
  • Keep nails as short as possible 5

Common Pitfalls to Avoid

  • Inadequate treatment duration: Continue treatment for at least one week after clinical clearing of infection 6
  • Ignoring concomitant onychomycosis: Up to one-third of diabetics have onychomycosis, which significantly predicts foot ulcer development and requires concurrent treatment 1
  • Failing to address environmental sources: Shoes can contain large numbers of infective fungal elements that cause reinfection 5
  • Not examining other body sites: Dermatophyte infections commonly occur at multiple body sites simultaneously, with concomitant infections confirmed in 25% of cases 1

References

Guideline

Treatment of Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinea pedis: clinical experience and efficacy of short treatment.

Dermatology (Basel, Switzerland), 1997

Research

Tinea pedis: an updated review.

Drugs in context, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.